STAT+: Roche drug sets new standard for KRAS-driven lung cancer

A turning point for pancreatic cancer patients

Recent moves of note in and around the biotech and pharma industries

Anne Wojcicki Wins Bidding for 23andMe

Manufacturing and regulatory hurdles threaten cell and gene therapy progress

The article discusses how manufacturing and regulatory challenges are hindering the progress of cell and gene therapies, particularly in can

BioTradingArena: AI Biotech Trading Benchmark with 655 Validated Catalyst Cases

BioTradingArena is a benchmark dataset for AI-driven biotech trading, containing 655 validated biotech catalyst cases with linked clinical t

China creates new regulatory pathway to accelerate access to advanced biomedical therapies

China has established a new regulatory "tech track" for advanced therapies like personalized cancer treatments, cell and gene therapies, and